Mariam Ebrahim

Clinical oncologist with 10 years of experience, previously served as Consultant Clinical Oncologist at Assiut University Hospital, Egypt. Participated in the Medical Training Initiative (MTI) program and a clinical research fellowship at the Christie in the United Kingdom. Focused on enhancing skills and knowledge in cancer management to deliver high-quality holistic patient care. Committed to integrating global best practices into clinical approaches.

• RCR
• ESCO graduate
• ESMO member
• ESO member
• ASCO in training member
• ESGO member
• ESDO member
• Northern Ireland society of oncology member
• AACR
• EORTC
• ISLB

• National:
• The second-best oral presentation in 25th Annual Scientific conference of Alexandria clinical oncology department, 2022, awarded for 6 weeks training in radiotherapy department, Loyola university, Chicago.
• ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology, Cyprus, January 2020.
• International:
• ePoster presentation of abstract under title of "Capecitabine in CMT, case report and review of literature", EANO, October 2025.
• ESCO educational grant to attend ASCO annual meeting, Chicago, 2024.
• ESMO breast 2023, Berlin as a winner of oncolympics (local competition between different oncological departments in Egypt)
• ESO virtual mentorship program with professor Pierfrancesco Franco, and ASCO virtual mentorship program with Professor Ulka Vaishampayan, 2022-2023.
• ICF registration scholarship to participate in ESMO congress online 2022.
• Improving cancer outcome and leadership course, ESO, ECO, SPCC initiative, Warsaw, July 2022.
• ESMO world congress on gastro-intestinal cancer, Barcelona, July 2022. As a part of CAS-GI.
• my master thesis was about NAR score (neo-adjuvant rectal cancer score) as a prognostic factor in locally advanced cancer rectum, in clinical oncology department, Assiut university hospital which was accepted for poster presentation in ESMO GI congress, Barcelona, Spain, July 2019 and the abstract was published on annals of oncology journal.

• Finalizing the North West Cancer Center’s Application for ESMO Accreditation.

In recognition of the exceptional efforts of our palliative care team at the North West Cancer Center (NWCC) and the quality of service they provide to our patients, I successfully finalized the application for ESMO accreditation.

As a result, NWCC has been accredited as an ESMO Designated Center of Integrated Oncology and Palliative Care for the period 2025-2027.

This prestigious accreditation acknowledges our commitment to excellence in palliative care and positions us as a leader in the field.

The official announcement and award ceremony took place in Barcelona, Spain, during the ESMO Congress, providing international recognition of our achievements.

• Establishing a Nutrition Unit for Oncology Patients.

As a dedicated member of the Clinical Oncology Department at Assiut University, I played an integral role in establishing a nutrition unit for oncology patients, particularly those with head and neck tumors, before the commencement of CCRTH. This initiative was part of our broader efforts to enhance the palliative care unit and has since led to the creation of a unique and comprehensive palliative care clinic that stands out in Upper Egypt.

Our goal was to improve the quality of life and treatment outcome for these patients through tailored nutritional support.

Being part of the project, the steps of establishment included:

1. Initial Planning and Collaboration: The establishment of the nutrition unit required meticulous planning and collaboration with various stakeholders, including oncologists, dietitians, nurses, and hospital administrators. We conducted a thorough needs assessment to understand the specific nutritional challenges faced by our patients.

2. Designing the Unit: We designed the nutrition unit to provide comprehensive services, including nutritional assessments, individualized diet plans, and counseling. The unit was equipped with state-of-the-art facilities to support the preparation and administration of specialized diets.

3. Training and Development: To ensure the effectiveness of the nutrition unit, we invested in the training and development of our staff. Dietitians received specialized training in oncology nutrition, focusing on the unique needs of head and neck tumor patients. Our team also participated in workshops and seminars to stay updated on the latest advancements in the field.

4. Implementation and Integration: The implementation phase involved integrating the nutrition unit into the existing palliative care framework.

• I have had the distinct honor of being part of the organization committee for the International Conference of the Clinical Oncology Department at Assiut University for four consecutive years, from 2021 to 2025.

This role has been a significant opportunity to develop and showcase my leadership and organizational skills while contributing to the advancement of clinical oncology on an international stage.

My role included:

1. Planning and Coordination: My responsibilities involved meticulous planning and coordination of various conference activities. This included collaborating with fellow committee members to set the conference agenda, identifying and inviting keynote speakers, and ensuring that all logistical arrangements were in place.

2. Speaker and Participant Management: One of my key roles was to manage communications with invited speakers and participants.

3. On-Site Management: During the conference, I oversaw on-site management, ensuring that all sessions ran smoothly, addressing any issues promptly, and coordinating with volunteers and support staff.

4. Post-Conference Activities: Post-conference, I was involved in gathering feedback from participants, analyzing the success of the conference, and identifying areas for improvement.

• Uploading Medical Photos on Hospital System:

Background: Previously, photos of medical issues such as skin toxicities were stored only in patient paper files, making them inaccessible for follow-up consultations, especially during out-of-hours (OOH) consultations. This limitation hindered timely and accurate management of patient conditions.

Initiative: To address this issue, I collaborated with the PACS system manager to create a clear and secure pathway for uploading these medical photographs into the PACS system.

This initiative involved:

- Coordination with IT and PACS Managers: Working closely with the PACS system manager to ensure the technical feasibility of uploading and storing medical photos within the existing system infrastructure.

- Development of Protocols: Establishing protocols to ensure that the process of uploading photos adheres to patient confidentiality data and data protection regulations. Outcome: The integration of medical photos into the PACS system will significantly improve the accessibility of these images to the entire medical team.

- This enhancement allows for accurate and timely management of medical issues, particularly during OOH consultations, without compromising patient confidentiality. As a result of the success of this project, the trust expands this initiative to hospitals of the trust, not only NWCC, and will pass to encompass.

• Waiting time for colorectal cancer treatment as colorectal cancer outcomes are heavily dependent on how quickly treatment begin following diagnosis. By analysis whether waiting times in NWCC meet UK performance standards, identify delays and their causes, paving the way for actionable improvements.

• Role of primary radiotherapy in inoperable breast cancer patients. The project provides a beacon of hope for patients who cannot undergo surgery due to advanced disease, comorbidities, or frailty, demonstrating the effectiveness of radiotherapy in improving survival and quality of life.

• In my role as a demonstrator and assistant lecturer in academic center at the Clinical Oncology Department, Assiut University, Egypt, I have been actively involved in the academic and clinical education of medical students, junior doctors, healthcare professionals, and undergraduate clinical pharmacy students.
• My teaching responsibilities include:
• Course Presentations: Delivering several presentations on critical topics in clinical oncology, such as:

- Management of Small Cell Lung Cancer (SCLC)

- ROS1 in the Management of Non-Small Cell Lung Cancer (NSCLC)

-Radiation Therapy in Cancer of the Pharynx and Larynx

- Progress in Cancer Pancreas Management- PARP Inhibitors in the Management of Platinum-Sensitive Relapsing Ovarian Cancer

- Updates in the Treatment of HER2 Neu Positive Breast Cancer

These presentations have been instrumental in enhancing the knowledge and skills of students and colleagues in the field of oncology.

• Weekly Teaching Sessions at NWCC: Actively participating in weekly teaching sessions at the Northwest Cancer Centre (NWCC), where I provide comprehensive education on the best practices for managing cancer patients.

These sessions include junior doctors and other healthcare professionals, ensuring that the team members are well-oriented about the latest advancements and standards in oncology care.

• Undergraduate Clinical Pharmacy Education: Teaching undergraduate clinical pharmacy students about oncology pharmacotherapy, including the mechanisms, indications, side effects, and management of chemotherapeutic agents and targeted therapies. This role involves lecturing, conducting practical sessions, and evaluating student performance.
• Mentorship and Guidance: Mentoring medical students and junior doctors, offering guidance on clinical decision-making, patient management, and research methodologies. This mentorship helps nurture the next generation of oncologists and fosters a collaborative learning environment.
• Curriculum Development: Contributing to the development and updating of the clinical oncology curriculum to ensure it includes the latest research findings, treatment modalities, and clinical guidelines. This ensures that the education provided is current and relevant to modern oncology practice.

• Being part of academic center at Assiut University Hospital, I have been actively involved in various research projects, contributing significantly to the academic and clinical understanding of oncology.
• My experience in research includes:

- Methodological Expertise: Gaining a good foundation in research methodologies, including study design, data collection, statistical analysis, and interpretation of results. This has enabled me to contribute effectively to the planning and execution of research projects.

- Clinical Trial Involvement: Recently joining a clinical trial team after successfully completing the Good Clinical Practice (GCP) course in NWCC. This certification has equipped me with the knowledge and skills necessary to conduct clinical trials ethically and in compliance with international standards.

- Collaboration and Networking: Working closely with a multidisciplinary team of researchers, clinicians, and academics, fostering a collaborative environment that enhances the quality and impact of research outcomes.

- Publication and Dissemination: Contributing to the publication of research findings in peer-reviewed journals and presenting at national and international conferences. This has helped in disseminating knowledge and advancing the field of oncology.

- Patient-Centered Research: Ensuring that research projects are patient centered, with a focus on improving clinical practices and patient outcomes based on evidence-based findings.

Onsite courses: -Advanced communication skills training course, NWCC, November 2024. - Northern Ireland Society of oncology Autum educational meeting, October 2024.

Online courses: 

-E-proton school, the Christie, 2025. 

-R studio for data management, 2025.

-Comprehensive Online Course on Oncology Research and 

-IRMER course, IPEM, January 2025.

- Deprivation of Liberty level 2, 3, 4 course, December 2024.

- Introduction To Good Clinical Practice (GCP) course, 18/06/2024.

- Regional Appraisal Training (Appraisee) for medical staff, online, 12/04/2024.

- Information Governance Awareness, online,08/03/2024.

- Manual Handling Awareness, online, 07/03/2024.

- RCR 3D printing in Radiotherapy: Bolus and Beyond, online, 03/04/2024.

- Q2020; Attributes Framework Level 1, online, 27/02/202.

- LBT: Blood Components and Indications for Use, online, 23/02/2024.

- Fire Safety Awareness [WHSCT], online, 20/02/2024.

- Cyber Security Awareness (Regional), online, 16/02/2024.

- Equality, Good Relations and Human Rights: Making a Difference, online, 14/02/2024.

- Acute Transfusion Reactions course, 09/02/2024.

- Haemovigilance course, 07/02/2024.

- Writing Methodology Course: How to produce high-quality research paper, 21/01/2024.

- Online Writing Methodology course, from European School of Oncology.

- ESMO Virtual Advanced Course on NTRK Gene Fusion: A New Target in Precision Treatment of Cancer, December 2022.

- Transatlantic exchange in immune oncology virtually, 13 May 2022.

- ELCC virtual event, March 2022.

- AI in cancer diagnosis virtual event, 2021 and I have been awarded an

EACR-Worldwide Cancer Research Meeting Bursary to support my attendance including a complimentary conference registration and EACR membership.

- ESMO Virtual Advanced Course on Clinical Questions in Prostate Cancer, March 2021.

- ESMO Gynaecological Cancers Virtual Congress 2021.

- ESMO Breast Cancer Virtual Meeting 2021.

- CJC multiple myloma virtual event, July 2021.

- CJC transforming hormone sensitive metastatic prostate carcinoma management virtual event, July 2021.

- ESTRO live webinar proton flash therapy virtual meeting, June 2020.

- 9th Red Sea Best of ASCO 2020 virtual meeting, June 2020.

- ESMO Breast Cancer Virtual Meeting 2020.

- Professional Audit awareness course, 26/09/2024.

- ESMO Congress, Barcelona, Spain, September 2024.

- ASCO annual meeting, Chicago, May 2024.

- Northern Ireland Society of oncology Spring educational meeting, May 2024.

- Immediate life support course, 25/04/2024.

- Basic life support course from AHA, January 2023.

- ESTRO workshop in prostate brachytherapy and stereotactic radiotherapy for

brain tumors, Cairo, September 2022.

- Course in basic statistics and best way to use SPSS, Assiut university, July 2022.

- Improving cancer outcome and leadership course, ESO, ECO, SPCC initiative, Warsaw, July 2022.

- BGICC, Cairo, January 2022.- CJC lung cancer 360 forum, Ismailia, February, 2020.

- International annual conference of Assuit Clinical Oncology Department, Luxor, February 2020.

- ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology, Cyprus, January 2020.

- Training session about criticizing mCRC from biostatistics perspective, Cairo, September 2019.

- Workshop about basic life support in accordance with the curriculum the American Heart Association Basic Life Support program, Assuit University, September 2019.

- Workshop of infection control, Assuit University, February 2019.

- Training in 3D delineation for 3-month, Cairo University, 2018.

- Workshop in how to write a research protocol, Assiut University, July 2018.

- Workshop in evidence-based medicine, Assiut University, July. 2018.

- Workshop in writing medical reports, Assuit University, July 2018.

- Lung cancer master class by ESMO, Assuit, October 2018.

- Immuno-oncology course, Cairo, December 2017.

- Workshop about how to deal with clinical trials, Assuit University, September 2017.

- Workshop on head and neck cancer delineation by ESMO, Luxor, Egypt, February 2016.

- Basic course of Ethical, Law and administrative considerations in medical practice, Assuit University, February 2015.

- Basic course of Cardio-Pulmonary Resuscitation, Assuit University, June 2014.

- Basic course of infection control, Assuit University, November 2014.

- Basic course of Electrocardiogram analysis in Assuit University, March 2013.

- Successfully passed all modules required for the granting of ICDL, Assuit University, May 2012.

- Basic course of surgical suturing and skills, Assuit University, December 2011.

- Basic course of Surgical first aids, first aid of fractures and burns, Assuit University, September 2011.

National: International:

- The second-best oral presentation in 25th Annual Scientific conference of Alexandria clinical oncology department, 2022, awarded for 6 weeks training in radiotherapy department, Loyola university, Chicago.

- ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology, Cyprus, January 2020.

- ESCO educational grant to attend ASCO annual meeting, Chicago, 2024.

- ESMO breast 2023, Berlin as a winner of oncolympics (local competition between different oncological departments in Egypt)

- ESO virtual mentorship program with professor Pierfrancesco Franco, and ASCO virtual mentorship program with Professor Ulka Vaishampayan, 2022-2023.

- ICF registration scholarship to participate in ESMO congress online 2022.

- Improving cancer outcome and leadership course, ESO, ECO, SPCC initiative, Warsaw, July 2022.

- ESMO world congress on gastro-intestinal cancer, Barcelona, July 2022. As a part of CAS-GI.

- my master thesis was about NAR score (neo-adjuvant rectal cancer score) as a prognostic factor in locally advanced cancer rectum, in clinical oncology department, Assiut university hospital which was accepted for poster presentation in ESMO GI congress, Barcelona, Spain, July 2019 and the abstract was published on annals of oncology journal

1. Evaluation of efficacy and toxicity of neo-adjuvant short course radiation therapy concurrently with continuous infusion 5-Fluorouracil in management of locally advanced rectal cancer patients

Authors: Radwan Torky, Mariam Mohsen Khalil, Taha Zaky, Mostafa Elsayed, Abeer Fayek, Maha Salah

Publication date: 2023/6/1

Journal: Bulletin of Pharmaceutical Sciences Assiut University

Issue: 1

Pages: 389-397

DOI:10.21608/BFSA.2023.301130

Purpose: To assess the safety and efficacy of neo-adjuvant short-course radiation therapy (SCRT) concurrently with continuous infusion of 5-fluorouracil (5-FU) in the treatment of locally advanced rectal cancer.

Authors: Ereny Samwel Poles Saad, HebatAllah Mahmoud Bakri, Amal Rayan, Dina Barakat, Mariam Mohsen Khalel

Publication date: 2022

Journal: e-cancermedicalscience

Publisher: e-cancer Global Foundation

DOI: 10.3332/ecancer.2022.1353

Publication date: 2019/7/1 Journal: Annals of Oncology Volume: 30

Pages: iv14-iv15

Publisher: Elsevier

DOI:https://doi.org/10.1093/annonc/mdz155.052

Methods: We reviewed the clinical data of patients with locally advanced rectal cancer treated at the Clinical Oncology Department of Assiut University Hospital between January 2009 and December 2013. Included were 70 patients who all received neo-adjuvant concurrent chemoradiotherapy followed by radical surgery. A 2D planning system by conventional X-ray simulation was used with the patient in a prone position, with radiation delivered by linear accelerator (SIEMENS PRIMUS Linear Accelerator) with energy at 15Mev. A total radiation dose of 5040 cGy and fraction size of 180 cGy, was used 5 times per week for 6 weeks concurrently with 5FU 400mg/m2 IV bolus+ leucovorin 20mg/m2 IV bolus from days 1-4 during weeks 1 and 5 of radiotherapy or use of capecitabine 825mg/m2 twice daily concurrently with radiation from days 1-5 and repeat cycle weekly for 5 weeks.

Authors: Rehab F Mohamed, M Mohsen Khalil, Samir Eid

Publication date: 2019 Journal: Cancer Biology Volume: 9

Issue: 3

Pages: 52-60

The aim of this study is determination of NAR score for locally advanced rectal cancer patients and its relationship with disease free survival (DFS) and overall survival (OS).

- "Capecitabine in Charcot-Marie-Tooth Disease (CMT): Case Report and Review of Literature".

Summary: This case report examines the use of Capecitabine in a patient with Charcot-Marie-Tooth disease, highlighting challenges and therapeutic considerations.

Summary: This case report investigates the potential of Streptokinase in managing loculated ascites, exploring an innovative approach to a complex clinical problem.

Summary: It is a prospective cohort study aimed at nutritional screening for all cancer patients receiving active treatment in Clinical Oncology Department, Assiut University Hospital in the period from March- September 2021.